Quantcast
Last updated on April 18, 2014 at 13:10 EDT

Latest Intraocular pressure Stories

2013-01-25 23:01:50

The Boston Eye Group announced today it has implanted the first device allowing remote intraocular pressure monitoring in patients with Glaucoma. Glaucoma is the second most common cause of blindness in the United States. Brookline, MA (PRWEB) January 25, 2013 Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to...

Glaucoma Research Points To Potential Early Indicator
2013-01-02 13:21:05

Lee Rannals for redOrbit.com - Your Universe Online A new study has found that certain changes in blood vessels in the eye's retina can be an early sign that a person may have an increased risk of glaucoma. Researchers wrote in the journal Ophthalmology that they found that patients who have abnormally narrow retinal arteries are more likely to develop glaucoma 10 years down the road. The research could eventually provide ophthalmologists with a new tool to identify and treat those...

2012-10-30 07:26:46

BEDFORD, Mass., Oct. 30, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced promising results of their sustained release travoprost (OTX-TP2) study for the treatment of glaucoma and ocular hypertension. OTX-TP2, a drug-eluting intracanalicular plug inserted through the punctum, was evaluated for the reduction of elevated intraocular pressure over a two-month period. The pilot Phase II study enrolled twenty patients (36 eyes) at the Umhlanga Hospital Medical Centre and Netcare...

2012-10-01 20:18:33

Study in October's Ophthalmology journal may lead to preventive treatment for groups at risk for glaucoma People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most common form of glaucoma, according to a nationwide study of more than 300,000 patients. A University of Michigan School of Medicine research team, directed by Joshua Stein, MD, MS, found that the risk for glaucoma was reduced by eight percent in patients who took statins...

2012-09-24 23:00:19

A new study shows promising results for those suffering from glaucoma. Anthony Economou, a glaucoma specialist, is excited about the news the study brings. New York, New York (PRWEB) September 24, 2012 A new study brings good news for glaucoma patients. Continuous intraocular pressure measurement with a contact lens senor was deemed safe and tolerable with repeated use. Though mild adverse effects were common, researchers still believe the study is a positive for those who suffer from the...

2012-08-20 10:23:57

BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release drug (OTX-TP2) for the treatment of ocular hypertension and glaucoma. Ocular Therapeutix's travoprost punctum plugs are inserted into the proximal nasolacrimal canal, and release drug to the ocular surface over the two-month treatment period. The...

2012-07-23 10:25:44

BEDFORD, Mass., July 23, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period. Twenty six eyes were treated in 17 patients at the Singapore National Eye Center and the National...

2012-05-04 18:20:21

BEDFORD, Mass., May 4, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. Up to twenty patients will be enrolled at Singapore National Eye Center and the National University Hospital in Singapore. Patients with documented ocular hypertension or open-angle glaucoma are eligible for the study. Primary endpoints include intraocular pressure reduction from...

2012-04-05 21:07:01

A six-year collaboration between two faculty members of Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has yielded new insight regarding the regulation of intraocular pressure (IOP) in glaucoma — an irreversible blinding disease that causes progressive visual impairment due to optic nerve damage and is the leading cause of blindness worldwide. The key finding by associate professors of ophthalmology Richard K. Lee, M.D., Ph.D., and Sanjoy...

2012-03-19 16:59:32

Jackson Laboratory researchers identify new damaging mechanism Jackson Laboratory researchers have demonstrated that a single, targeted x-ray treatment of an individual eye in young, glaucoma-prone mice provided that eye with apparently life-long and typically complete protection from glaucoma. In research published March 19 in the Journal of Clinical Investigation, Gareth Howell, Ph.D., Simon John, Ph.D., (professor and Howard Hughes Medical Investigator) and colleagues also used...